Timothy Chevassut

2.1k total citations
42 papers, 1.2k citations indexed

About

Timothy Chevassut is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Timothy Chevassut has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Hematology and 7 papers in Genetics. Recurrent topics in Timothy Chevassut's work include Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Timothy Chevassut is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Timothy Chevassut collaborates with scholars based in United Kingdom, United States and Germany. Timothy Chevassut's co-authors include Helen Stewart, Gillian A. Horne, Bernard Ramsahoye, Nick Gilbert, Melany Jackson, John Ansell, Lesley M. Forrester, Sarah F. Newbury, Eleni E Ladikou and Andrea Pepper and has published in prestigious journals such as Nature, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Timothy Chevassut

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Chevassut United Kingdom 18 876 429 194 129 105 42 1.2k
Anders Castor Sweden 18 455 0.5× 755 1.8× 132 0.7× 309 2.4× 136 1.3× 46 1.5k
Hussein A. Abbas United States 18 524 0.6× 392 0.9× 160 0.8× 279 2.2× 141 1.3× 79 1.1k
Christophe Willekens France 18 375 0.4× 453 1.1× 143 0.7× 186 1.4× 162 1.5× 50 946
Jason H. Mendler United States 13 322 0.4× 298 0.7× 150 0.8× 198 1.5× 129 1.2× 53 787
Victoria Bedell United States 16 431 0.5× 218 0.5× 79 0.4× 181 1.4× 108 1.0× 40 1.0k
Suzanne Vercauteren Canada 16 303 0.3× 331 0.8× 87 0.4× 94 0.7× 114 1.1× 60 842
Marina Petrini Italy 18 734 0.8× 195 0.5× 418 2.2× 175 1.4× 176 1.7× 38 1.2k
Francesco La Rocca Italy 20 592 0.7× 218 0.5× 308 1.6× 253 2.0× 166 1.6× 62 1.3k
Sylvie Martel France 19 580 0.7× 96 0.2× 101 0.5× 197 1.5× 164 1.6× 31 1.1k
Bhavana Bhatnagar United States 17 390 0.4× 438 1.0× 85 0.4× 299 2.3× 93 0.9× 79 877

Countries citing papers authored by Timothy Chevassut

Since Specialization
Citations

This map shows the geographic impact of Timothy Chevassut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Chevassut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Chevassut more than expected).

Fields of papers citing papers by Timothy Chevassut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Chevassut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Chevassut. The network helps show where Timothy Chevassut may publish in the future.

Co-authorship network of co-authors of Timothy Chevassut

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Chevassut. A scholar is included among the top collaborators of Timothy Chevassut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Chevassut. Timothy Chevassut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leongamornlert, Daniel, Nicholas Williams, Xin Wang, et al.. (2025). Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia. Nature. 640(8060). 982–990. 2 indexed citations
2.
Goff, A.K., Mathew Raynor, Erika J. Mancini, et al.. (2025). β-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells. Oncogene. 44(29). 2490–2503. 2 indexed citations
3.
4.
Jones, John R, Erika J. Mancini, Timothy Chevassut, et al.. (2024). Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data. Blood Cancer Journal. 14(1). 105–105. 2 indexed citations
5.
Palmer, David A., et al.. (2022). A Single-Centre Experience of Post-COVID-19 Vaccine-Related Immune-Mediated Complications. SHILAP Revista de lepidopterología. 2022. 1–6. 1 indexed citations
6.
Kong, Robert, Nevil Hutchinson, Nicola Skipper, et al.. (2022). Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). British Journal of Anaesthesia. 128(5). 796–805. 26 indexed citations
7.
Ladikou, Eleni E, et al.. (2022). Acute leukaemia: no reason to panic. Clinical Medicine. 22(3). 221–224.
8.
Chevassut, Timothy, et al.. (2022). Thrombocytopenia: the good, the bad and the ugly. Clinical Medicine. 22(3). 214–217. 6 indexed citations
9.
Mitchell, Simon, et al.. (2022). Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma. Hematological Oncology. 40(3). 417–429. 5 indexed citations
10.
Picaud, S., Régis Millet, Gilles Gasser, et al.. (2021). Probing BRD Inhibition Substituent Effects in Bulky Analogues of (+)‐JQ1. Helvetica Chimica Acta. 104(3). 1 indexed citations
11.
Ladikou, Eleni E, et al.. (2020). Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia. Current Oncology Reports. 22(3). 27–27. 53 indexed citations
12.
Tung, Joanna Yuet‐ling, et al.. (2019). <p>Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis</p>. Journal of Blood Medicine. Volume 10. 199–208. 11 indexed citations
13.
Dempke, Wolfram C. M., Peter Uciechowski, Klaus Fenchel, & Timothy Chevassut. (2018). Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?. Oncology. 95(5). 257–269. 55 indexed citations
14.
Rau, Rachel E., Blanca Rodríguez, Min Luo, et al.. (2016). DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 128(7). 971–981. 95 indexed citations
15.
Chowdhury, Basudev, Andrew McGovern, Yi Cui, et al.. (2015). The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells. Scientific Reports. 5(1). 9281–9281. 31 indexed citations
16.
Robinson, Sophie, Antony W. Oliver, Timothy Chevassut, & Sarah F. Newbury. (2015). The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease. Biomolecules. 5(3). 1515–1539. 44 indexed citations
17.
Horne, Gillian A., Helen Stewart, Jacqueline Dickson, et al.. (2014). Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1. Stem Cells and Development. 24(7). 879–891. 39 indexed citations
18.
Rider, Tom, Muzaffar Malik, & Timothy Chevassut. (2014). Haematology patients and the internet – The use of on-line health information and the impact on the patient–doctor relationship. Patient Education and Counseling. 97(2). 223–238. 40 indexed citations
19.
Jones, Christopher I., Maria V. Zabolotskaya, Helen Stewart, et al.. (2012). Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. British Journal of Cancer. 107(12). 1987–1996. 110 indexed citations
20.
Stewart, Helen, et al.. (2010). The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma. Experimental Hematology. 39(3). 330–338. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Castor Breakdown of academic impact, for papers by Hussein A. Abbas Breakdown of academic impact, for papers by Christophe Willekens Breakdown of academic impact, for papers by Jason H. Mendler Breakdown of academic impact, for papers by Victoria Bedell Breakdown of academic impact, for papers by Suzanne Vercauteren Breakdown of academic impact, for papers by Marina Petrini Breakdown of academic impact, for papers by Francesco La Rocca Breakdown of academic impact, for papers by Sylvie Martel Breakdown of academic impact, for papers by Bhavana Bhatnagar
Rankless by CCL
2026